| Delivery of P-glycoprotein substrates using chemosensitizers and nanotechnology for selective and efficient therapeutic outcomes RN Montesinos, A Béduneau, Y Pellequer, A Lamprecht Journal of controlled release 161 (1), 50-61, 2012 | 91 | 2012 |
| Coadministration of P-glycoprotein modulators on loperamide pharmacokinetics and brain distribution RN Montesinos, B Moulari, J Gromand, A Beduneau, A Lamprecht, ... Drug Metabolism and Disposition 42 (4), 700-706, 2014 | 58 | 2014 |
| Structural and Functional Analysis of Female Sex Hormones against SARS-CoV-2 Cell Entry JA Aguilar-Pineda, M Albaghdadi, W Jiang, KJ Vera-Lopez, ... International journal of molecular sciences 22 (21), 11508, 2021 | 23 | 2021 |
| Diagnosis of Alzheimer’s Disease in Developed and Developing Countries: Systematic Review and Meta-Analysis of Diagnostic Test Accuracy MA Chávez-Fumagalli, P Shrivastava, JA Aguilar-Pineda, ... Journal of Alzheimer's disease reports 5 (1), 15-30, 2021 | 20 | 2021 |
| Liposomal Drug Delivery to the Central Nervous System RN Montesinos Liposomes, 2017 | 19 | 2017 |
| Liposomes Coloaded with Elacridar and Tariquidar To Modulate the P-Glycoprotein at the Blood–Brain Barrier R Nieto Montesinos, A Béduneau, A Lamprecht, Y Pellequer Molecular pharmaceutics 12 (11), 3829-3838, 2015 | 18 | 2015 |
| Vascular smooth muscle cell dysfunction contribute to neuroinflammation and Tau hyperphosphorylation in Alzheimer disease JA Aguilar-Pineda, KJ Vera-Lopez, P Shrivastava, MA Chávez-Fumagalli, ... Iscience 24 (9), 102993, 2021 | 17 | 2021 |
| Drug delivery to the central nervous system RMN Montesinos Université de Franche-Comté, 2014 | | 2014 |
